Given the research-backed benefits, even beyond weight loss and blood sugar regulation, Satish Garg, MD, has a bold prediction: I have no doubt in my mind: Going forward, this class of drugs is going to be used by the vast majority of people with type 1 diabetes. Heres what you need to know about the benefits of this treatment and the notable risks
These individuals may have already tried lifestyle modifications, including dietary changes and increased physical activity, but have not achieved the desired results
Ultimately, they reflect the fact that levels of drug exposure will vary based on a universal one-size-fits-all dosing regimen
This dual-agonist approach not only helps lower blood sugar but may also improve how the body processes sugar and fat
Excellent summary and infographic by Ahmad Bahareth, MD